Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash Flows from Operating Activities:    
Net Loss $ (14,562) $ (16,643)
Reconciliation of net loss to net cash used in operating activities:    
Depreciation and amortization expense 682 4
Amortization of debt discount 246 369
Amortization of product revenue license fee 133 0
Amortization of forgivable loans to registered representatives 201 0
Amortization of deferred clearing credit (52) 0
Stock-based compensation expense 2,929 2,866
Recovery for doubtful accounts (115) 0
Issuance of subsidiaries' common shares for license expenses 30 48
Financing fees on subsidiaries' Convertible Note, at fair value 4 0
Change in fair value of investments 668 918
Change in fair value of derivative liabilities (4,342) 89
Change in fair value of subsidiary convertible note 97 0
Change in fair value of contingent consideration payable 7  
Research and development-licenses acquired, expense 1,265 35
Increase (decrease) in cash and cash equivalents resulting from changes in operating assets and liabilities:    
Accounts receivable 462 0
Receivables from broker-dealers and clearing organizations 499 0
Forgivable loans receivable (17) 0
Securities owned, at fair value 1,151 0
Inventory (1) 0
Other receivables - related party 756 (1,158)
Prepaid expenses and other current assets 635 (166)
Accounts payable and accrued expenses (1,882) 169
Securities sold, but not yet purchased, at fair value (297) 0
Interest payable 2 0
Interest payable - related party 30 0
Other long-term liabilities (4) 1,832
Net cash used in operating activities (11,475) (11,637)
Cash Flows from Investing Activities:    
Purchase of research and development licenses (665) (35)
Purchase of property and equipment (261) (2,293)
Purchase of license 0 (200)
Security deposits refund 3 0
Acquisition of business - National (19) 0
Investment in Origo Acquisition Corp. 0 (175)
Net cash used in investing activities (942) (2,703)
Cash Flows from Financing Activities:    
Proceeds from subsidiary's offering 55,904 570
Payment of costs related to subsidiary's offering (2,998) (205)
Payment of NSC Note 0 (2,792)
Proceeds from 2017 Subordinated Note Financing 3,254 0
Proceeds from Opus Credit Facility 2,000 0
Net cash provided by (used in) financing activities 58,160 (2,427)
Net increase (decrease) in cash and cash equivalents 45,743 (16,767)
Cash and cash equivalents at beginning of period 88,294 98,182
Cash and cash equivalents at end of period 134,037 81,415
Supplemental disclosure of cash flow information:    
Cash paid for interest 58 77
Supplemental disclosure of non-cash financing and investing activities:    
Issuance of restricted stock 1 2
Issuance of warrants to National as placement agent in conjunction with NSC Debt 206 0
Debt discount related to Opus Credit Facility 158 0
Common shares issuable for license acquired $ 1,682 $ 0